While many renal diseases have been shown to progress at different rates between the sexes, these findings indicate that there are differential pathologic pathways governed by gonadal steroids, with testosterone promoting a GH-dependent, hypertrophic renal growth, and 17β-estradiol promoting IGF-1-associated hyperplastic renal growth[16,17,23]. This evidence concerns the gene GH1 and kidney disorder.